Good News for Nigeria as Global Fund Gives $660 Million To Fight HIV, TB, Malaria
The Global Fund, an international financing organisation, has announced an additional humanitarian grant of $660 million to tackle HIV/AIDS, Tuberculosis and Malaria epidemic in Nigeria.
Peter Sands, Its Executive Director, announced this at a news conference on Wednesday, October 24, 2018, in Abuja.
Sands noted that the grant will be made available in tranches for three years.
“Nigeria has remained a country in which Global Fund had invested tremendously in the past because of its highest burden of Malaria, Tuberculosis, HIV and AIDS.
“We have invested about $2.6 billion to tackle these epidemics in the past and we intend to do more to get more people on treatment.
“We appreciate the hard work in the outcome of the partnership between the government and global fund but we believe that we still have a lot of work to do.
“For HIV and AIDS, we want more people on treatment; we also want to prevent mother-to-child transmission.
“We also want to reduce malaria related deaths and we want to ensure that the percentage of people on tuberculosis treatment increases.
“Above all, we will like to see a return on our investments,” he said.
Sani Aliyu, the director-general, National Agency for the Control of AIDS, NACA, appreciated the continuous support of Global Fund in the healthcare sector of the country.
Aliyu noted that the country would have continued to struggle to deliver quality healthcare services without the support of Global Fund.
“The country is making progress in the aspect of HIV and AIDS as a lot of patients are already on treatment.
“Presently and with the support of grants such as this, we have about 1.1 million people on treatment.
“We cannot have grants like this without including more people on treatment,” he added.
Isaac Adewole, the minister of health, assured the organisation of judicious use of the grant.
“We look forward to another visit where we will showcase positive results from your investment,’’ he said.
Get full news at Vanguard